Andrew Obenshain - Net Worth and Insider Trading

Andrew Obenshain Net Worth

The estimated net worth of Andrew Obenshain is at least $157,111 dollars as of 2025-01-12. Andrew Obenshain is the President and CEO of bluebird bio Inc and owns about 18,571 shares of bluebird bio Inc (BLUE) stock worth over $157,111. Details can be seen in Andrew Obenshain's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Obenshain has not made any transactions after 2025-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew Obenshain

To

Andrew Obenshain Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Obenshain owns 1 companies in total, including bluebird bio Inc (BLUE) .

Click here to see the complete history of Andrew Obenshain’s form 4 insider trades.

Insider Ownership Summary of Andrew Obenshain

Ticker Comapny Transaction Date Type of Owner
BLUE bluebird bio Inc 2024-12-10 President of SGD

Andrew Obenshain Latest Holdings Summary

Andrew Obenshain currently owns a total of 1 stock. Andrew Obenshain owns 18,571 shares of bluebird bio Inc (BLUE) as of January 6, 2025, with a value of $157,111.

Latest Holdings of Andrew Obenshain

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BLUE bluebird bio Inc 2025-01-06 18,571 8.46 157,111

Holding Weightings of Andrew Obenshain


Andrew Obenshain Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Obenshain has made a total of 17 transactions in bluebird bio Inc (BLUE) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in bluebird bio Inc is the sale of 140 shares on January 6, 2025, which brought Andrew Obenshain around $1,294.

Insider Trading History of Andrew Obenshain

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Obenshain Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Obenshain Ownership Network

Ownership Network List of Andrew Obenshain

No Data

Ownership Network Relation of Andrew Obenshain

Insider Network Chart

Andrew Obenshain Owned Company Details

What does bluebird bio Inc do?

Who are the key executives at bluebird bio Inc?

Andrew Obenshain is the President of SGD of bluebird bio Inc. Other key executives at bluebird bio Inc include Chief Medical Officer Richard A Colvin , Chief Commercial Officer & SGD Thomas J Klima , and Chief Business & Legal Officer Joseph Vittiglio .

bluebird bio Inc (BLUE) Insider Trades Summary

Over the past 18 months, Andrew Obenshain made 7 insider transaction in bluebird bio Inc (BLUE) with a net sale of 29,983. Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 12,553 shares made by Richard A Colvin , a net sale of 12,043 shares made by Thomas J Klima , and a net sale of 5,217 shares made by Joseph Vittiglio .

In summary, during the past 3 months, insiders sold 349 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 349 shares. During the past 18 months, 3,367 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,367 shares.

bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

bluebird bio Inc Insider Transactions

No Available Data

Andrew Obenshain Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Obenshain. You might contact Andrew Obenshain via mailing address: C/o Bluebird Bio, Inc., 455 Grand Union Boulevard, Somerville Ma 02145.